Advanced search
Start date

In vivo and in vitro treatment with n-acetylcysteine and deferoxamine in dystrophic mice

Luis Henrique Rapucci Moraes
Total Authors: 1
Document type: Doctoral Thesis
Institution: Universidade Estadual de Campinas (UNICAMP). Instituto de Biologia
Defense date:
Examining board members:
Valéria Helena Alves Cagnon Quitet; Jesus Carlos Andreo; Maeli Dal Pai; Selma Maria Michelin Matheus
Advisor: Elaine Minatel

Due the fact of mdx mice, an experimental model of Duchenne muscular dystrophy, presenting the lipid peroxidation of membrane caused by increased production of reactive oxygen species (ROS) in the period that preced the onset of muscle fibers degeneration, it is suggested that stress oxidative may be one of the primary mechanisms of dystrophic muscle degeneration, rather than a side effect of this process. Mdx mice treated with the antioxidant N-acetylcysteine (NAC) showed a decrease in muscle degeneration. According to the literature the association of NAC with Deferoxamine (DFX) produces more effective results against oxidative stress than NAC alone. Thus, the aim of this study was to verify, through morphological analysis, cellular and biochemistry, if the in vivo and in vitro treatment with the combination of NAC and DFX decreases the ROS production. For in vivo studies were used C57BL/10 mice (control group) and mdx mice, with 14 days postnatal. The mdx and C57BL/10 mice were divided into 4 experimental groups: treated with saline, treated with NAC + DFX, treated with DFX and treated with NAC (150 mg/kg) for 14 days. All animals were subjected to strength measurement analysis. The Sternomastoid (STN), Diaphragm (DIA) and Tibialis anterior (TA) muscles were removed and submitted to histological techniques (HE, Evans blue dye and DHE reaction), Western Blotting (TNF-?, NF-kB, MyoD, MAFbx and 4-HNE). Blood plasma was used for determination of Creatine kinase (CK) and inflammatory cytokines. In the in vitro experiments, the muscles of the pelvic limb of C57BL/10 and mdx mice with 14 days postnatal were used. The muscles culture cells were used for cell viability analysis (Trypan blue, MTT and Neutral red), calcium analysis and Western blotting after being treated or not with NAC and DFX. Treatment with NAC , DFX and NAC + DFX showed benefic effect on dystrophic muscle fibers, both in vivo and in vitro experiments, reducing muscle degeneration, exacerbated inflammation, lipid peroxidation, and ROS production. Either the isolated or the combination treatment of medication showed a potential effect, however in some experiments the combination was more effective against the damage caused by the disease. (AU)

FAPESP's process: 10/01087-4 - In vivo and in vitro treatment, with N-acetylcistein and Deferoxamin in dystrophic mouse
Grantee:Luis Henrique Rapucci Moraes
Support type: Scholarships in Brazil - Doctorate